Home > Press > Kodak Launches New Imaging Agent Product Line for Research Applications
Enables Early Disease Detection and Treatment
Kodak Launches New Imaging Agent Product Line for Research Applications
New Haven, CT | Posted on February 28th, 2007
Eastman Kodak Company's Molecular Imaging Systems group announced the introduction of KODAK X-SIGHT Imaging Agents, a novel line of imaging agents for in vivo molecular imaging applications. The new product line will be shown at the 14th International Molecular Medicine Tri-Conference, beginning today in San Francisco, Calif., and running through March 2.
In vivo molecular imaging allows non-invasive measurement of biological processes within a living organism. In contrast to conventional diagnostic imaging that highlights conditions caused by disease, molecular imaging identifies molecular abnormalities that are the origin of disease at a very early stage, which can expedite the development of treatment options that could help cure that disease.
Once attached to a molecule and injected into an organism, the KODAK X-Sight imaging agents will travel to the target (such as a tumor) and highlight the region of interest. X-Sight imaging agents are non-toxic, making them safe for research studies in areas such as oncology, cardiology, diabetes, and inflammation, to name a few. They are uniquely designed to offer significant advantages over currently available agents, enabling researchers to perform pioneering research studies that could lead to a better understanding of the origin of these diseases.
This new product line leverages Kodak's 50 years of dye chemistry and nanotechnology expertise, to produce state-of-the-art nanoparticle products. X-Sight imaging agents deliver superior brightness and enhanced stability, providing researchers a versatile platform for molecular imaging. KODAK X-Sight imaging agents are available in several distinct varieties and can be adapted to a wide range of applications.
"The launch of X-Sight Imaging Agents, is a significant milestone toward offering our customers a complete solution of systems and agents to advance their research," commented Shahram Hejazi, PhD, Worldwide General Manager of Kodak's Molecular Imaging Systems division. "This introduction strengthens our leadership in the molecular imaging arena as we move forward to bridge the gap between preclinical and clinical applications."
Together with Kodak's In-Vivo Imaging Systems, the X-Sight Imaging Agent product line further expands the breadth of leading edge solutions offered from Kodak to the medical research community to accelerate life science and drug discovery research. X-Sight imaging agents are currently available for preclinical use in the United States and will be launched worldwide in March. Kodak plans to introduce additional imaging agents throughout the year.
About Kodak’s Molecular Imaging Systems Group
Eastman Kodak Company’s Molecular Imaging Systems group--part of Kodak’s Health Group--develops and markets high performance digital imaging systems, imaging agents, film and accessories for the life science research and drug discovery/development market segments.
For more information, visit http://www.kodak.com/go/molecular or call 1-877-747-4357, express code 7. Outside of the United States, call 203-786-5657.
Kodak and X-Sight are trademarks of Eastman Kodak Company.
For more information, please click here
Eastman Kodak Company
Alice Huang, 408-464-1151
Copyright © Business Wire
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Patent for the Novel Cancer Therapies – Ceramide Nanoliposomes March 4th, 2015
Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015
Democratizing synthetic biology: New method makes research cheaper, faster, and more accessible March 3rd, 2015
Pens filled with high-tech inks for do-it-yourself sensors March 3rd, 2015
Anousheh Ansari Wins the National Space Society's Space Pioneer Award for "Service to the Space Community" March 5th, 2015
Enhanced Graphene Components for Next Generation Racing Yacht March 5th, 2015
Get ready for NanoDays! March 5th, 2015
American Chemical Society Presidential Symposia: nanoscience, international chemistry March 5th, 2015
Keysight Technologies Shifts to Direct Sales of High-Performance Products in North America March 3rd, 2015
Forbidden quantum leaps possible with high-res spectroscopy March 2nd, 2015
International research partnership tricks the light fantastic March 2nd, 2015
Important step towards quantum computing: Metals at atomic scale March 2nd, 2015